🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21461Original Research

Biocompatibility and preclinical experiments of a Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes

Li Yujin¹,Ni Guansen¹,Mao Weiqing¹,Tang Jiayu¹,Li Xueqing¹

Shanghai Fifth People's Hospital, Fudan University

Read Executive PreviewQuick FAQ
Biocompatibility and preclinical experiments of a Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1903, Issue 31 • pp. 100-112Citation:Li Yujin et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Chinese-made 3D-printed tungsten alloy needle electrodes exhibit no significant cytotoxicity, skin irritation, or sensitization, confirming good biocompatibility. • Compared with 304 stainless steel electrodes, the 3D-printed tungsten alloy electrodes significantly reduce tissue adhesion, though they increase intraoperative blood loss and smoke formation. • The performance of Chinese-made 3D-printed tungsten alloy electrodes is comparable to imported tungsten alloy electrodes in terms of adhesion, blood loss, and smoke formation. • Postoperative wound healing and histological outcomes are similar among stainless steel, imported tungsten, and Chinese-made tungsten electrodes, indicating safety for clinical use.
Sponsored Research Highlight

Abstract

BACKGROUND: The increasing prevalence of minimally invasive surgery has placed higher demands on high-frequency electrosurgical equipment. Imported minimally invasive tungsten alloy electrodes offer high cutting precision, low tissue adhesion, and good biocompatibility, but their high cost limits their widespread application. Therefore, conducting biocompatibility and preclinical animal studies on Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes can provide a scientific basis for the research and development of Chinese-made minimally invasive electrodes. OBJECTIVE: To evaluate the biocompatibility and preclinical safety of Chinese-made 3D-printed tungsten alloy needle-shaped electrodes. METHODS: (1) Biocompatibility: L-929 cells were co-cultured with extracts from Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes at different concentrations (100%, 50%, 25%, and 12.5%), and the cytotoxicity of the materials was assessed using the MTT assay. Intradermal stimulation experiments were performed on New Zealand white rabbits to evaluate the skin irritation of the Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes. Skin sensitization was evaluated in albino guinea pigs. (2) Preclinical animal experiments: 36 SD rats were randomly divided into three groups (n=12 per group): 304 stainless steel electrode group, imported minimally invasive tungsten alloy needle electrode group, and Chinese-made 3D-printed minimally invasive tungsten alloy needle electrode group. The corresponding electrodes were used to cut subcutaneous tissue and abdominal wall muscle, and the incisions were sutured. The amount of adherent material on the electrode surface, intraoperative blood loss, and smoke formation were recorded. At 14 days postoperatively, wound healing, fat liquefaction, and histological morphology of the incision were observed. RESULTS AND CONCLUSION: (1) MTT assay showed that the cell survival rate in the extract group of Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes was higher than 80%, indicating no obvious cytotoxicity. Intradermal stimulation and sensitization tests showed no significant skin irritation or sensitization reaction. (2) Compared with the 304 stainless steel electrode group, the Chinese-made 3D-printed minimally invasive tungsten alloy needle electrode group had reduced electrode surface adhesion, increased intraoperative blood loss and smoke formation (P < 0.05). There were no significant differences between the Chinese-made and imported tungsten alloy needle electrode groups in terms of electrode surface adhesion, intraoperative blood loss, and smoke formation (P > 0.05). There were no significant differences among the three groups in wound healing, fat liquefaction, and incision adverse reactions (P > 0.05). Hematoxylin-eosin staining showed mild inflammatory cell infiltration in all three groups, consistent with normal wound repair pathology, with no abnormal immune reaction or delayed healing. (3) The results indicate that Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes have good biocompatibility and safety, with overall performance comparable to imported tungsten needle electrodes.

1. Introduction

With the development of minimally invasive surgical techniques, high-frequency electrosurgical equipment has been widely used in clinical operations, offering advantages such as rapid cutting, reduced blood loss, simple operation, low cost, and broad applicability [1-3]. As the core component of high-frequency electrosurgical equipment, the surgical electrode's performance directly affects surgical precision and safety. Among various materials, stainless steel has good biocompatibility and is easy to process, making it one of the most widely used surgical electrode materials [4-5]. However, the commonly used 304 stainless steel electrode, despite its good electrical conductivity, has significant drawbacks in practice: the electrode tip diameter is relatively large (typically >1 mm), making precise tissue cutting difficult in delicate procedures such as thyroidectomy and otolaryngological microsurgery. Moreover, under high temperatures, tissue carbonization and adhesion on the electrode surface can occur, increasing the risk of secondary injury and potentially causing abnormal current conduction, thereby affecting surgical safety. Clinical complications in minimally invasive surgery are directly related to electrode performance deficiencies [4], highlighting the technical bottlenecks of existing materials. Therefore, developing new electrode materials to reduce electrode adhesion and enhance precision is crucial for advancing high-frequency electrodes in minimally invasive surgery. Medical metal materials currently used clinically include stainless steel, titanium alloys, cobalt-based alloys, as well as precious metals such as gold, silver, and tungsten, and shape memory alloys [6-7].

Compared with traditional stainless steel, tungsten alloys are considered ideal electrode materials due to their high melting point (3,410 °C), low thermal expansion coefficient (4.5×10-6/K), and excellent mechanical strength [8-10]. Tungsten alloys exhibit good corrosion resistance and surface stability, closely related to their high melting point [11]. Additionally, tungsten has a low electron work function and is often used as electrical contact material in high-voltage circuit breakers resistant to arc erosion [12]. Furthermore, tungsten possesses good biocompatibility [13], chemical inertness, and corrosion resistance [9,14], making it a promising candidate for surgical electrodes.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Li Yujin, Ni Guansen, Mao Weiqing, Tang Jiayu, Li Xueqing (2026). Biocompatibility and preclinical experiments of a Chinese-made 3D-printed minimally invasive tungsten alloy needle electrodes. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21461
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the biocompatibility of Chinese-made 3D-printed tungsten alloy needle electrodes?

The study demonstrated that Chinese-made 3D-printed tungsten alloy needle electrodes have good biocompatibility, as evidenced by no significant cytotoxicity (cell viability >80%), no skin irritation in rabbits, and no sensitization in guinea pigs.

How do Chinese-made 3D-printed tungsten alloy electrodes compare to 304 stainless steel electrodes in terms of tissue adhesion?

Chinese-made 3D-printed tungsten alloy electrodes significantly reduce tissue adhesion compared to 304 stainless steel electrodes, as indicated by a lower amount of adherent material on the electrode surface during surgery.

Are Chinese-made 3D-printed tungsten alloy electrodes as safe as imported tungsten alloy electrodes?

Yes, the study found no significant differences between Chinese-made and imported tungsten alloy electrodes in terms of electrode surface adhesion, intraoperative blood loss, smoke formation, and postoperative wound healing, indicating comparable safety and performance.

What were the outcomes of the preclinical animal experiments?

In the preclinical animal experiments using SD rats, all three electrode groups (stainless steel, imported tungsten, and Chinese-made tungsten) showed similar wound healing and histological findings, with only mild inflammatory cell infiltration consistent with normal wound repair, and no abnormal immune reactions or delayed healing.

What is the significance of this study for clinical practice?

This study provides scientific evidence supporting the clinical application of Chinese-made 3D-printed tungsten alloy needle electrodes as a cost-effective alternative to imported electrodes, potentially reducing healthcare costs while maintaining high surgical precision and safety.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF